<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1012-2966</journal-id>
<journal-title><![CDATA[Gaceta Médica Boliviana]]></journal-title>
<abbrev-journal-title><![CDATA[Gac Med Bol]]></abbrev-journal-title>
<issn>1012-2966</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Medicina de la Universidad Mayor de San Simón]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1012-29662024000200094</article-id>
<article-id pub-id-type="doi">10.47993/gmb.v47i2.902</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Serum Interleukin-6 seems to be comparable in patients with type 2 diabetes and those with impaired fasting glucose]]></article-title>
<article-title xml:lang="es"><![CDATA[Comparación de interleucina-6 entre pacientes con Diabetes Mellitus tipo 2 y pacientes con glucosa elevada en ayunas]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hashim]]></surname>
<given-names><![CDATA[Raid D.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Naji Alsharifi]]></surname>
<given-names><![CDATA[Nabigh A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nathir]]></surname>
<given-names><![CDATA[Israa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aljubori]]></surname>
<given-names><![CDATA[Anas A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Al-Farahidi University College of Pharmacy ]]></institution>
<addr-line><![CDATA[Baghdad ]]></addr-line>
<country>Iraq</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Al-Farahidi University College of Pharmacy ]]></institution>
<addr-line><![CDATA[Baghdad ]]></addr-line>
<country>Iraq</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Al-Rasheed University College Department of Pharmacy ]]></institution>
<addr-line><![CDATA[Baghdad ]]></addr-line>
<country>Iraq</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Al-Farahidi University College of Pharmacy ]]></institution>
<addr-line><![CDATA[Baghdad ]]></addr-line>
<country>Iraq</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2024</year>
</pub-date>
<volume>47</volume>
<numero>2</numero>
<fpage>94</fpage>
<lpage>105</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S1012-29662024000200094&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S1012-29662024000200094&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S1012-29662024000200094&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Prediabetes is a relatively common medical problem that is supposed to precede the development of diabetes mellitus. Many trials have been performed to predict the transformation of prediabetes into frank diabetes mellitus depending on the alterations in certain biomarkers related to inflammation. The current study aims to estimate serum interleukin-6 (IL-6) in individuals with impaired fasting glucose and compare it to that of patients with new-onset type 2 diabetes mellitus.  Methods:  This cross-sectional study enrolled 159 randomly selected participants who were equally classified according to their history and laboratory findings into healthy control, prediabetes and newly diagnosed diabetes mellitus groups. Serum IL-6 was measured in all participants and statistically compared and correlated with body mass index (BMI) and glycated hemoglobin (HbA1c).  Results:  The mean serum IL-6 has shown no significant difference between the control and prediabetes groups while it was significantly higher in the diabetes group compared to both control and prediabetes groups. In addition, a poor correlation has been revealed between serum IL-6 and HbA1c.  Conclusión:  The absence of a sustained increase in serum IL-6 in the 3 studied groups questions its beneficial role as a predictor of the progression of type 2 diabetes from the prediabetes state.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La prediabetes (glucosa elevada) es un problema médico relativamente común que se supone precede al desarrollo de la diabetes mellitus. Se han realizado numerosos ensayos para predecir la transformación de la prediabetes en diabetes mellitus franca en función de las alteraciones en determinados biomarcadores relacionados con la inflamación. El estudio actual tiene como objetivo estimar la interleucina-6 sérica (IL-6) en individuos con glucosa elevada en ayunas y compararla con la de pacientes con diabetes mellitus tipo 2 de nueva aparición.  Métodos:  Este estudio transversal inscribió a 159 participantes seleccionados al azar que fueron clasificados igualmente según su historia y hallazgos de laboratorio en grupos de control saludable, prediabetes y diabetes mellitus recién diagnosticada. Se midió la IL-6 sérica en todos los participantes y se comparó y correlacionó estadísticamente con el índice de masa corporal (IMC) y la hemoglobina glucosilada (HbAlc).  Resultados:  La IL-6 sérica media no mostró diferencias significativas entre los grupos de control y prediabetes, mientras que fue significativamente mayor en el grupo de diabetes en comparación con los grupos de control y prediabetes. Además, se ha revelado una mala correlación entre la IL-6 sérica y la HbAlc.  Conclusión:  La ausencia de un aumento sostenido de la IL-6 sérica en los 3 grupos estudiados cuestiona su papel beneficioso como predictor de la progresión de la diabetes tipo 2 desde el estado de prediabetes.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[IL-6]]></kwd>
<kwd lng="en"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[prediabetes]]></kwd>
<kwd lng="en"><![CDATA[HbAlc]]></kwd>
<kwd lng="es"><![CDATA[IL-6]]></kwd>
<kwd lng="es"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[prediabetes]]></kwd>
<kwd lng="es"><![CDATA[HbAlc]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Saeedi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Karuranga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pinkepank]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ogurtsova]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[BB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IDF Diabetes Atlas Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045]]></article-title>
<source><![CDATA[Diabetes research and clinical practice]]></source>
<year>2022</year>
<volume>183</volume>
<page-range>109119</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bain]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kanamarlapudi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives]]></article-title>
<source><![CDATA[Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy]]></source>
<year>2021</year>
<volume>14</volume>
<page-range>3567-602</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsalamandris]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Antonopoulos]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Oikonomou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Papamikroulis]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Vogiatzi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Papaioannou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Role of Inflammation in Diabetes Current Concepts and Future Perspectives]]></article-title>
<source><![CDATA[Eur Cardiol]]></source>
<year>2019</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hotamisligil]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Shargill]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Spiegelman]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adipose expression of tumor necrosis factor-a direct role in obesity-linked insulin resistance]]></article-title>
<source><![CDATA[Science]]></source>
<year>1993</year>
<volume>259</volume>
<numero>5091</numero>
<issue>5091</issue>
<page-range>87-91</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rohm]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Meier]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Olefsky]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Donath]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammation in obesity, diabetes, and related disorders]]></article-title>
<source><![CDATA[Immunity]]></source>
<year>2022</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-55</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nwadiugwu]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammatory activities in type 2 diabetes patients with co-morbid angiopathies and exploring beneficial interventions a systematic review]]></article-title>
<source><![CDATA[Frontiers in Public Health]]></source>
<year>2021</year>
<volume>8</volume>
<page-range>600427</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choy]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rose-John]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interleukin-6 as a Multifunctional Regulator Inflammation, Immune Response, and Fibrosis]]></article-title>
<source><![CDATA[Journal of Scleroderma and Related Disorders]]></source>
<year>2017</year>
<volume>2</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S1-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uciechowski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dempke]]></surname>
<given-names><![CDATA[WCM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interleukin-6 A Masterplayer in the Cytokine Network]]></article-title>
<source><![CDATA[Oncology]]></source>
<year>2020</year>
<volume>98</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>131-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diagnosis and classification of diabetes mellitus]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
<volume>32</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S62-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rehman]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Akash]]></surname>
<given-names><![CDATA[MSH]]></given-names>
</name>
<name>
<surname><![CDATA[Liaqat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kamal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Qadir]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Rasul]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus]]></article-title>
<source><![CDATA[Crit Rev Eukaryot Gene Expr]]></source>
<year>2017</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>229-36</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Association]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2 Classification and diagnosis of diabetes: standards of medical care in diabetes-2020]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2020</year>
<volume>43</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S14-31</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haw]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Galaviz]]></surname>
<given-names><![CDATA[KI]]></given-names>
</name>
<name>
<surname><![CDATA[Straus]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Kowalski]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Magee]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term sustainability of diabetes prevention approaches a systematic review and meta-analysis of randomized clinical trials]]></article-title>
<source><![CDATA[JAMA internal medicine]]></source>
<year>2017</year>
<volume>177</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1808-17</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Committee]]></surname>
<given-names><![CDATA[ADAPP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2 Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2021</year>
<volume>45</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S17-38</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Danu Atmaja]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Orno]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Yuniarty]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Malik]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation Analysis of Interleukin-6 on Blood Glucose in Prediabetes and Normal Glycemic Status]]></article-title>
<source><![CDATA[Medical Laboratory Technology Journal]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hossain]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Faruque]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Kabir]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sikdar]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Nahar]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of serum TNF-a and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population]]></article-title>
<source><![CDATA[International Journal of Diabetes Mellitus]]></source>
<year>2010</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>165-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ayelign]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Negash]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Andualem]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wondemagegn]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kassa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shibabaw]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of IL-10 (- 1082 A/G) and IL-6 (- 174 G/C) gene polymorphism with type 2 diabetes mellitus in Ethiopia population]]></article-title>
<source><![CDATA[BMC Endocrine Disorders]]></source>
<year>2021</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>70</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gillies]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pendharkar]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Asrani]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Mathew]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Windsor]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Petrov]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interleukin-6 is associated with chronic hyperglycemia and insulin resistance in patients after acute pancreatitis]]></article-title>
<source><![CDATA[Pancreatology]]></source>
<year>2016</year>
<volume>16</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>748-55</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siewko]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Maciulewski]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zielinska-Maciulewska]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Poplawska-Kita]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Szumowski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wawrusiewicz-Kurylonek]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interleukin-6 and Interleukin-15 as Possible Biomarkers of the Risk of Autoimmune Diabetes Development]]></article-title>
<source><![CDATA[Biomed Res Int]]></source>
<year>2019</year>
<volume>2019</volume>
<page-range>4734063</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-a and IL-6]]></article-title>
<source><![CDATA[Diabetes research and clinical practice]]></source>
<year>2005</year>
<volume>69</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-35</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nash]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Butcher]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Aicheler]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cullen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[IL-6 signaling in acute exercise and chronic training Potential consequences for health and athletic performance]]></article-title>
<source><![CDATA[Scandinavian Journal of Medicine &amp; Science in Sports]]></source>
<year>2023</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-19</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cullen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interleukin-6 and associated cytokine responses to an acute bout of high-intensity interval exercise the effect of exercise intensity and volume]]></article-title>
<source><![CDATA[Applied physiology, nutrition, and metabolism]]></source>
<year>2016</year>
<volume>41</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>803-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
